Genetic susceptibility to infectious disease.

Our understanding of the variation in individual clinical responses to pathogens has become increasingly relevant, particularly in the face of new emerging epidemics as well as the increasing number of multi-drug-resistant organisms. An effective immune response to infection has contributed to the development of host genetic diversity through selective pressure, with an increasing number of studies characterizing the role that host genetics plays in disease susceptibility. Knowledge of the role host mechanisms play in the pathogenesis of infectious disease can contribute to the design of new therapeutic strategies. Rapid advances in the field of human genomics offer great opportunities for adopting this approach to find new insights into pathogenesis.

[1]  Eric S. Lander,et al.  The mosaic structure of variation in the laboratory mouse genome , 2002, Nature.

[2]  D. Malo,et al.  Genetic control of host resistance to infection. , 1994, Trends in genetics : TIG.

[3]  R. Pitchappan,et al.  A major susceptibility locus for leprosy in India maps to chromosome 10p13 , 2001, Nature Genetics.

[4]  A. Hart,et al.  Mouse genetic model for clinical and immunological heterogeneity of leishmaniasis , 2002, Immunogenetics.

[5]  R. Locksley,et al.  TH1 and TH2 cell antigen receptors in experimental leishmaniasis. , 1993, Science.

[6]  T. Baldwin,et al.  Temporal expression of an H2-linked locus in host response to mouse malaria , 1999, Immunogenetics.

[7]  T. Hudson,et al.  Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population , 2003, Nature Genetics.

[8]  J. Blackwell,et al.  Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. , 1979, Clinical and experimental immunology.

[9]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[10]  H. Whittle,et al.  Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. , 1998, The New England journal of medicine.

[11]  G. Snell,et al.  HISTOCOMPATIBILITY GENES OF MICE VII. H‐13, A NEW HISTOCOMPATIBILITY LOCUS IN THE FIFTH LINKAGE GROUP , 1967, Transplantation.

[12]  M. Schalling,et al.  Multigenic Control of Disease Severity after Virulent Mycobacterium tuberculosis Infection in Mice , 2003, Infection and Immunity.

[13]  M. Grisotto,et al.  Pathology Affects Different Organs in Two Mouse Strains Chronically Infected by a Trypanosoma cruzi Clone: a Model for Genetic Studies of Chagas’ Disease , 2004, Infection and Immunity.

[14]  T. Ottenhoff,et al.  Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae , 2002, Nature Genetics.

[15]  A. Hart,et al.  Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes , 2000, Genes and Immunity.

[16]  H. Thomas,et al.  Heterozygote advantage for HLA class-II type in hepatitis B virus infection , 1997, Nature Genetics.

[17]  R. Bellamy.  The natural resistance-associated macrophage protein and susceptibility to intracellular pathogens. , 1999, Microbes and infection.

[18]  J. Wain,et al.  Genes of the class II and class III major histocompatibility complex are associated with typhoid fever in Vietnam. , 2001, The Journal of infectious diseases.

[19]  D. Kwiatkowski,et al.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. , 1994, Nature.

[20]  W. Dietrich,et al.  Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  A. Borrego,et al.  Co-localization of quantitative trait loci regulating resistance to Salmonella typhimurium infection and specific antibody production phenotypes. , 2002, Microbes and infection.

[22]  D. Bailey.  RECOMBINANT‐INBRED STRAINS AN AID TO FINDING IDENTITY, LINKAGE, AND FUNCTION OF HISTOCOMPATIBILITY AND OTHER GENES , 1971, Transplantation.

[23]  M. Newport,et al.  Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. , 2002, The Journal of infectious diseases.

[24]  P. Gros,et al.  Pyruvate kinase deficiency in mice protects against malaria , 2003, Nature Genetics.

[25]  D. Bradley,et al.  Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice. , 1977, Clinical and experimental immunology.

[26]  C. Haley,et al.  Fine mapping of trypanosomiasis resistance loci in murine advanced intercross lines , 2000, Mammalian Genome.

[27]  B. M. Greenwood,et al.  Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria , 1995, Nature.

[28]  M. Coluzzi,et al.  Different response to Plasmodium falciparum malaria in west African sympatric ethnic groups. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Alpers,et al.  alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Goedert,et al.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.

[31]  R. Stoughton,et al.  Genetics of gene expression surveyed in maize, mouse and man , 2003, Nature.

[32]  R. Appelberg,et al.  Susceptibility of beige mice to Mycobacterium avium: role of neutrophils , 1995, Infection and immunity.

[33]  A. Björkman,et al.  Falciparum malaria and beta-thalassaemia trait in northern Liberia. , 1983, Annals of tropical medicine and parasitology.

[34]  B. Taylor,et al.  Genetic regulation of resistance to intracellular pathogens , 1982, Nature.

[35]  A. Hill.  Immunogenetics and genomics , 2001, The Lancet.

[36]  L. Cardon,et al.  Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice , 2000, Genes and Immunity.

[37]  L. Cardon,et al.  Association study designs for complex diseases , 2001, Nature Reviews Genetics.

[38]  C. Hale,et al.  Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tvopica in mice , 1980, Parasite immunology.

[39]  J. Blackwell,et al.  Influence of Lsh, H-2, and an H-11-linked gene on visceralization and metastasis associated with Leishmania mexicana infection in mice , 1989, Infection and immunity.

[40]  A. Hart,et al.  Different Genetic Control of Cutaneous and Visceral Disease after Leishmania major Infection in Mice , 2003, Infection and Immunity.

[41]  T. Hodge,et al.  Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele. , 1997, Emerging infectious diseases.

[42]  G. Bancroft,et al.  Increased susceptibility to cytomegalovirus infection in beige mutant mice. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Todd,et al.  Mononucleotide repeats are an abundant source of length variants in mouse genomic DNA , 2004, Mammalian Genome.

[44]  M. Petzl-Erler,et al.  Association of leprosy with HLA-DR2 in a Southern Brazilian population. , 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[45]  D. Kwiatkowski,et al.  Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. , 1997, The Journal of infectious diseases.

[46]  D. Malo,et al.  Mapping of genetic modulators of natural resistance to infection with Salmonella typhimurium in wild-derived mice. , 1998, Genomics.

[47]  L. Morel,et al.  Quantitative trait loci in Chromosomes 3, 8, and 9 regulate antibody production against Salmonella flagellar antigensin the mouse , 2004, Mammalian Genome.

[48]  M. Potter,et al.  GENETIC CONTROL OF LEISHMANIA MAJOR INFECTION IN CONGENIC, RECOMBINANT INBRED AND F2 POPULATIONS OF MICE , 1993, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[49]  T. Ley,et al.  Lymphocyte-mediated cytotoxicity. , 2003, Annual review of immunology.

[50]  B. Gazzard,et al.  Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. , 1999, The Journal of infectious diseases.

[51]  J. Nap,et al.  Genetical genomics : the added value from segregation , 2001 .

[52]  D. Malo,et al.  Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. , 1994, Genomics.

[53]  R. Graff,et al.  The Non‐H‐2 Histocompatibility Loci and Their Antigens , 1973, Transplantation reviews.

[54]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.

[55]  A. Hill,et al.  Genetics of infectious disease resistance. , 1996, Current opinion in genetics & development.

[56]  R. Williamson,et al.  Evidence for exclusion of a mutation in NRAMP as the cause of familial disseminated atypical mycobacterial infection in a Maltese kindred. , 1995, Journal of Medical Genetics.

[57]  G. Cooke,et al.  Genetics of susceptibitlity to human infectious disease , 2001, Nature Reviews Genetics.

[58]  T. Baldwin,et al.  Mouse loci for malaria-induced mortality and the control of parasitaemia , 1997, Nature Genetics.

[59]  M. Bix,et al.  A Leishmania major Response Locus Identified by Interval-specific Congenic Mapping of a T Helper Type 2 Cell Bias-controlling Quantitative Trait Locus , 2004, The Journal of experimental medicine.

[60]  D. Bradley.  Genetic control of natural resistance to Leishmania donovani , 1974, Nature.

[61]  J. Weissenbach,et al.  Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31–q33 , 1996, Nature Genetics.

[62]  J. Goedert,et al.  Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.

[63]  C. Bogdan,et al.  Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase , 1996, The Journal of experimental medicine.

[64]  M. Justice,et al.  Identification of the murine beige gene by YAC complementation and positional cloning , 1996, Nature Genetics.

[65]  A. C. Collins,et al.  A method for fine mapping quantitative trait loci in outbred animal stocks. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  H C Thomas,et al.  Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. , 1995, The New England journal of medicine.

[67]  E. Lander,et al.  Analysing complex genetic traits with chromosome substitution strains , 2000, Nature Genetics.

[68]  C. E. Kirkpatrick,et al.  Leishmaniasis in beige mice , 1982, Infection and immunity.

[69]  L. Cardon,et al.  Identification of a new malaria susceptibility locus (Char4) in recombinant congenic strains of mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[70]  D. Malo,et al.  Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg , 1993, Cell.

[71]  R. Mosher,et al.  Multigenic control of Listeria monocytogenes susceptibility in mice , 2001, Nature Genetics.

[72]  A. Hill,et al.  Genetic factors as determinants of infectious disease transmission in human communities. , 1988, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[73]  M. Lipoldová,et al.  Resistance to Leishmania major in mice. , 1996, Science.

[74]  C. Bogdan,et al.  Rapidly Fatal Leishmaniasis in Resistant C57BL/6 Mice Lacking TNF1 , 2001, The Journal of Immunology.

[75]  L. Nencioni,et al.  Genetic control of in vitro natural cell-mediated activity against Salmonella typhimurium by intestinal and splenic lymphoid cells in mice. , 1984, Clinical and experimental immunology.

[76]  J. Barnard,et al.  Tuberculosis associated with HLA--B8, BfS in a Newfoundland community study. , 1978, Tissue antigens.

[77]  L R Cardon,et al.  Extent and distribution of linkage disequilibrium in three genomic regions. , 2001, American journal of human genetics.

[78]  W. Dietrich,et al.  The Host Resistance Locus sst1 Controls Innate Immunity to Listeria monocytogenes Infection in Immunodeficient Mice1 , 2004, The Journal of Immunology.

[79]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[80]  P. Andersen,et al.  Genetic and environmental influences on premature death in adult adoptees. , 1988, The New England journal of medicine.

[81]  Mark Thursz,et al.  Influence of MHC class II genotype on outcome of infection with hepatitis C virus , 1999, The Lancet.

[82]  A. Hill,et al.  Genetic susceptibility to malaria and other infectious diseases: from the MHC to the whole genome , 1996, Parasitology.

[83]  S. Wakana,et al.  Influence of H2 complex and non-H2 genes on progression of cutaneous lesions in mice infected with Leishmania amazonensis. , 2004, Parasitology international.

[84]  R. Doerge,et al.  Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses , 2001, Genes and Immunity.

[85]  Jennifer J. Johnson,et al.  Genetic analysis of influences on survival following Toxoplasma gondii infection. , 2002, International journal for parasitology.

[86]  Andrew J. McMichael,et al.  Common West African HLA antigens are associated with protection from severe malaria , 1991, Nature.

[87]  R. Doerge,et al.  Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. , 1999, Journal of immunology.